Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Washington University School of Medicine
Eastern Cooperative Oncology Group
NKGen Biotech, Inc.
M.D. Anderson Cancer Center